GATA2 and COVID-19: Collectively, MkP- and GP-priming TFs, including ETS2, FLI1, SPI1, and GATA2 were activated in the HSC/MPP cells from COVID-19 patients, probably contributing to the increased output of myeloid progenitor cells and decreased output of lymphoid progenitors.